Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Abroad (travel likely)RecruitingPHASE2
Conditions
Severe Aplastic Anemia (SAA) · Hypo-Plastic Myelodysplastic Syndrome (MDS) · Paroxysmal Nocturnal Hemoglobinuria (PNH)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · prpl@cc.nih.gov · 800-411-1222
Study leads
Richard W Childs, M.D.
Principal Investigator
National Heart, Lung, and Blood Institute (NHLBI)